Tear function changes during interferon and ribavirin treatment in patients with chronic hepatitis C

Cornea

Volumn 24, Issue 5, 2005, Pages 561-566

  Huang, Fu Chin ^a   Shih, Min Hsiu ^a   Tseng, Sung Huei ^a,b   Lin, Shih Chin ^a   Chang, Ting Tsung ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NONE   (Taiwan)

Author keywords

Dry eye; Hepatitis C; Interferon; Ribavirin; Squamous metaplasia

Indexed keywords

ALPHA2B INTERFERON; FLUORESCEIN; PEGINTERFERON ALPHA2B; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DRY EYE; FEMALE; FUNCTION TEST; HEPATITIS C; HUMAN; MALE; PRIORITY JOURNAL; SCHIRMER TEST; SCORING SYSTEM; SLIT LAMP; SQUAMOUS CELL METAPLASIA; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; TEAR FLOW; VISUAL ACUITY;

ADULT; ANTIVIRAL AGENTS; CONJUNCTIVA; DRUG THERAPY, COMBINATION; DRY EYE SYNDROMES; EPITHELIAL CELLS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; LACRIMAL APPARATUS; MALE; METAPLASIA; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RIBAVIRIN; TEARS;

EID: 21244433212     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000151560.40236.70     Document Type: Article

References (30)

1. Siagris D, Pharmakakis N, Christofidou M, et al. Keratoconjunctivitis sicca and chronic HCV infection. Infection. 2002;30:229-233.
2. Abe T, Nakajima A, Matsunaga M, et al. Decreased tear lactoferrin concentration in patients with chronic hepatitis C. Br J Ophthalmol. 1999;83: 684-687.
3. Mariette X, Zerbib M, Jaccard A, et al. Hepatitis C virus and Sjögren's syndrome. Arthritis Rheum. 1993;36:280-281.
4. Haddad J, Deny P, Munz-Gotheil C, et al. Lymphocyte sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet. 1992;339:321-323.
5. Poynard T, Marcellin P, Lee SS, et al. Randomized trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet. 1998;352:1426-1432.
6. McHutchison JG, Gordon SC, Shiffman ML, et al. Interferon α2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med. 1998;339:1485-1492.
7. Guyer DR, Tiedeman J, Yannuzzi LA, et al. Interferon-associated retinopathy. Arch Ophthalmol. 1993;111:350-356.
8. Hayasaka S, Fujii M, Yamamoto Y, et al. Retinopathy and subconjunctival hemorrhage in patients with chronic hepatitis receiving interferon alfa. Br J Ophthalmol. 1995;79:150-152.
9. Kawano T, Shigehira M, Uto H, et al. Retinal complications during interferon therapy for chronic hepatitis C. Am J Gastroenterol. 1996;91: 309-313.
10. Tokai R, Ikeda T, Miyaura T, et al. Interferon-associated retinopathy and cystoid macular edema. Arch Ophthalmol. 2001;119:1077-1079.
11. Purvin VA. Anterior ischemic optic neuropathy secondary to interferon alfa. Arch Ophthalmol. 1995;113:1041-1044.
12. Cotler SJ, Wartelle CF, Larson AM, et al. Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C. J Viral Hepat. 2000;7:211-217.
13. Unoki H, Moriyama A, Tabaru A, et al. Development of Sjögren's syndrome during treatment with recombinant human interferon-α-2b for chronic hepatitis C. J Gastroenterol. 1996;31:723-727.
14. Davis GL, Esteban-Mur R, Rustgi V, et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med. 1998;339:1493-1499.
15. McHutchison JG, Poynard T. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C. Semin Liver Dis. 1999;19(suppl 1):57-65.
16. Xu KP, Yagi Y, Todal I, et al. Tear function index. Arch Ophthalmol. 1995; 113:84-88.
17. Tseng SCG. Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology. 1985;92:728-733.
18. Toda I, Shinozaki N, Tsubota K. Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjögren's syndrome. Cornea. 1996;15:120-128.
19. Kaye SB, Sims G, Willoughby C, et al. Modification of the tear function index and its use in the diagnosis of Sjögren's syndrome. Br J Ophthalmol. 2001;85:193-199.
20. Xu KP, Tsubota K. Correlation of tear clearance rate and fluorophotometric assessment of tear turnover. Br J Ophthalmol. 1995;79:1042-1045.
21. Schattner A. Interferons and autoimmunity. Am J Med Sci. 1988;295: 532-544.
22. Conlon KC, Urba WJ, Smith JW, et al. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer. 1990;65:2237-2242.
23. Gisslinger H, Gilly B, Woloszczuk W, et al. Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha. Clin Exp Immunol. 1992;90:363-367.
24. Mehta ND, Hooberman AL, Vokes EE, et al. 35-year-old patient with chronic myelogenous leukemia developing systemic lupus erythematosus after alpha-interferon therapy. Am J Hematol. 1992;41:141.
25. Schilling PJ, Kurzrock R, Kantarjian H, et al. Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. Cancer. 1991;68:1536-1537.
26. Hultgren C, Milich DR, Weiland O, et al. The antiviral compound ribavirin modulates the T helper (Th)1/Th2 subset balance in hepatitis B and C virus-specific immune response. J Gen Virol. 1998;79:2381-2391.
27. Martin J, Navas S, Quiroga JA, et al. Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients. Cytokine. 1998;10:635-644.
28. Shiffman ML, Verbeke SB, Kimball PM. Alpha interferon combined with ribavirin potentiates proliferative suppression but not cytokine production in mitogenically stimulated human lymphocytes. Antiviral Res. 2000;48: 91-99.
29. Geier SA, Libera S, Klauss V, et al. Sicca syndrome in patients infected with the human immunodeficiency virus. Ophthalmology. 1995;102: 1319-1324.
30. Pisella PJ, Brignole F, Debbasch C, et al. Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitts sicca. Ophthalmology. 2000;107:1841-1849.